Myomo/$MYO
1D1W1MYTD1Y5YMAX
Capital at risk
About Myomo
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.
- Ticker
- $MYO
- Sector
- Health
- Primary listing
- AMEX
- Employees
- 195
- Headquarters
- Burlington, United States
- Website
- myomo.com
Myomo Metrics
BasicAdvanced
$53M
-
-$0.37
1.44
-
Price and volume
Market cap
$53M
Beta
1.44
52-week high
$1.89
52-week low
$0.61
Average daily volume
682K
Financial strength
Current ratio
2.312
Quick ratio
1.734
Long term debt to equity
3.243
Total debt to equity
3.445
Interest coverage (TTM)
-6.54%
Profitability
EBITDA (TTM)
-10.517
Gross margin (TTM)
68.35%
Net profit margin (TTM)
-33.53%
Operating margin (TTM)
-27.05%
Effective tax rate (TTM)
-3.11%
Revenue per employee (TTM)
$220,000
Management effectiveness
Return on assets (TTM)
-19.76%
Return on equity (TTM)
-123.76%
Valuation
Price to revenue (TTM)
1.215
Price to book
9.02
Price to tangible book (TTM)
12.8
Price to free cash flow (TTM)
-5.786
Free cash flow yield (TTM)
-17.28%
Free cash flow per share (TTM)
-0.23
Growth
Revenue change (TTM)
6.14%
Earnings per share change (TTM)
48.70%
3-year revenue growth (CAGR)
35.43%
10-year revenue growth (CAGR)
49.99%
3-year earnings per share growth (CAGR)
-11.05%
10-year earnings per share growth (CAGR)
-43.87%
Upcoming events
No upcoming events
Myomo News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.